moved:
Motion No. 48
That Bill C-13, in Clause 20, be amended by adding after line 7 on page 11 the following:
“(5) The members of the Advisory Boards shall not, directly or indirectly, as owner, shareholder, director, officer, partner or otherwise, have any pecuniary or proprietary interest in any business which operates in the pharmaceutical or medical devices industries.”
Motion No. 49
That Bill C-13, in Clause 20, be amended by adding after line 7 on page 11 the following:
“(5) The Conflict of Interest and Post-Employment Code for Public Office Holders apply with such modifications as the circumstances require to the members of the Advisory Boards. For the purposes of the Code, “Public Office Holder” includes a member of an Advisory Board.”
Motion No. 50
That Bill C-13, in Clause 20, be amended by adding after line 7 on page 11 the following:
“20.1 (1) Within three months after the coming into force of this Act, the Governing Council shall make a by-law establishing a code of ethics for the members of the Advisory Boards.
(2) The by-law referred to in subsection (1) shall apply to the members of the Advisory Boards thirty days after it is made.”